Novo Nordisk Hits Biocon With IP Suit Over Weight Loss Drug
Novo Nordisk has slapped competitor Biocon Pharma with a drug patent suit in Delaware federal court over a generic version of weight loss treatment Saxenda, contending that it's too soon for...To view the full article, register now.
Already a subscriber? Click here to view full article